These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 12488556)

  • 21. Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells.
    Dai Y; Yu C; Singh V; Tang L; Wang Z; McInistry R; Dent P; Grant S
    Cancer Res; 2001 Jul; 61(13):5106-15. PubMed ID: 11431348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation.
    Rosato RR; Dai Y; Almenara JA; Maggio SC; Grant S
    Leukemia; 2004 Nov; 18(11):1780-8. PubMed ID: 15385934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic induction of apoptosis in human leukemia cells (U937) exposed to bryostatin 1 and the proteasome inhibitor lactacystin involves dysregulation of the PKC/MAPK cascade.
    Vrana JA; Grant S
    Blood; 2001 Apr; 97(7):2105-14. PubMed ID: 11264178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
    Grant S; Turner AJ; Bartimole TM; Nelms PA; Joe VC; Jarvis WD
    Oncol Res; 1994; 6(2):87-99. PubMed ID: 7949469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic antileukemic interactions between 17-AAG and UCN-01 involve interruption of RAF/MEK- and AKT-related pathways.
    Jia W; Yu C; Rahmani M; Krystal G; Sausville EA; Dent P; Grant S
    Blood; 2003 Sep; 102(5):1824-32. PubMed ID: 12738674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells.
    Wang Z; Su ZZ; Fisher PB; Wang S; VanTuyle G; Grant S
    Exp Cell Res; 1998 Oct; 244(1):105-16. PubMed ID: 9770354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemia.
    Cragg LH; Andreeff M; Feldman E; Roberts J; Murgo A; Winning M; Tombes MB; Roboz G; Kramer L; Grant S
    Clin Cancer Res; 2002 Jul; 8(7):2123-33. PubMed ID: 12114412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of bryostatin 1 on taxol-induced apoptosis and cytotoxicity in human leukemia cells (U937).
    Wang S; Guo CY; Castillo A; Dent P; Grant S
    Biochem Pharmacol; 1998 Sep; 56(5):635-44. PubMed ID: 9783732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of ara-C induced apoptosis in leukemia by the PKC activator bryostatin 1.
    Grant S
    Front Biosci; 1997 Jun; 2():d242-52. PubMed ID: 9195893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) promotes mitochondrial dysfunction and apoptosis induced by 7-hydroxystaurosporine and mitogen-activated protein kinase kinase inhibitors in human leukemia cells that ectopically express Bcl-2 and Bcl-xL.
    Dai Y; Dent P; Grant S
    Mol Pharmacol; 2003 Dec; 64(6):1402-9. PubMed ID: 14645670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells.
    Maggio SC; Rosato RR; Kramer LB; Dai Y; Rahmani M; Paik DS; Czarnik AC; Payne SG; Spiegel S; Grant S
    Cancer Res; 2004 Apr; 64(7):2590-600. PubMed ID: 15059916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of signal transduction mechanisms in human basophils and human skin mast cells. II. Effects of 7-O-methyl-UCN-01, NPC 15437 and bryostatin 1 and 2, four protein kinase C-modulatory agents, on mediator release.
    Noll T; Dieckmann D; Gibbs BF; Nitschke M; Albrecht C; Vollrath I; Tamaoki T; Wolff HH; Amon U
    Biol Signals; 1997; 6(1):1-10. PubMed ID: 9098518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of protein kinase C activator-mediated induction of p21CIP1 and p27KIP1 by deoxycytidine analogs in human leukemia cells: relationship to apoptosis and differentiation.
    Vrana JA; Kramer LB; Saunders AM; Zhang XF; Dent P; Povirk LF; Grant S
    Biochem Pharmacol; 1999 Jul; 58(1):121-31. PubMed ID: 10403525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of the Bcl-2 phosphorylation loop domain is required to protect human myeloid leukemia cells from flavopiridol-mediated mitochondrial damage and apoptosis.
    Decker RH; Wang S; Dai Y; Dent P; Grant S
    Cancer Biol Ther; 2002; 1(2):136-44. PubMed ID: 12170773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human THP-1 monocytic leukemic cells induced to undergo monocytic differentiation by bryostatin 1 are refractory to proteasome inhibitor-induced apoptosis.
    Chen C; Lin H; Karanes C; Pettit GR; Chen BD
    Cancer Res; 2000 Aug; 60(16):4377-85. PubMed ID: 10969781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of resistance to ara-C by bryostatin in fresh blast cells from patients with AML.
    Elgie AW; Sargent JM; Alton P; Peters GJ; Noordhuis P; Williamson CJ; Taylor CG
    Leuk Res; 1998 Apr; 22(4):373-8. PubMed ID: 9669842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 7-hydroxystaurosporine (UCN-01) and ionizing radiation combine to inhibit the growth of Bcl-2-overexpressing U937 leukemia cells through a non-apoptotic mechanism.
    Cartee L; Sankala H; Davis C; Smith R; Maggio S; Lin PS; Dent P; Grant S
    Int J Oncol; 2002 Aug; 21(2):351-9. PubMed ID: 12118331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of the expression of Bcl-2 and related proteins in human leukemia cells by protein kinase C activators: relationship to effects on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis.
    Bartimole TM; Vrana JA; Freemerman AJ; Jarvis WD; Reed JC; Boise LH; Grant S
    Cell Death Differ; 1997 May; 4(4):294-303. PubMed ID: 16465244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of bryostatin 1 and rGM-CSF on the metabolism of 1-beta-D-arabinofuranosylcytosine in human leukaemic myeloblasts.
    Grant S; Jarvis WD; Turner AJ; Wallace HJ; Pettit GR
    Br J Haematol; 1992 Nov; 82(3):522-8. PubMed ID: 1486032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells.
    Wen J; Ramadevi N; Nguyen D; Perkins C; Worthington E; Bhalla K
    Blood; 2000 Dec; 96(12):3900-6. PubMed ID: 11090076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.